A new Er(III)-based MOF showing anti-colon cancer activity by inhibiting IL-6-STAT3 signaling pathway and reducing TNF-α and IL-1β production-Reference-Cited by-同舟云学术

A new Er(III)-based MOF showing anti-colon cancer activity by inhibiting IL-6-STAT3 signaling pathway and reducing TNF-α and IL-1β production

Author:

Lv Changwei¹,Liu Yanwu²,Meng Guolin²,Li Jing³,Ti Zhenyu⁴

Affiliation:

1. Orthopaedic Department of Xi’an No.3 Hospital, Affiliated Hospital of Northwest University, Xi’an, Shaanxi, China;

2. Department of Orthopeadic, Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, China;

3. School of Chemical Engineering, Xi’an University, Xi’an, Shaanxi, China;

4. General Surgery Department of Xi’an No.3 Hospital, Affiliated Hospital of Northwest University, Xi’an, Shaanxi, China

Publisher

Informa UK Limited

Subject

Materials Chemistry,Physical and Theoretical Chemistry

Link

Reference28 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献